MODIFIZIERTE NUKLEOTID-LINKER

European patent · EP3564252 · In force

Register entry

Publication number
EP3564252
Application number
EP19178987
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 6, 2015
Published
Nov 6, 2019
Granted
Mar 17, 2021
Protection ends at the latest
Aug 5, 2035
Next annual fee due
Aug 31, 2026
IPC classes
C07H 19/14 (2006.01)
Priority
GB 201414098 08.08.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Sep 1, 2024

    Change

    Published in Swissreg on 01.09.2024

  3. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  4. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  5. Jan 26, 2022

    Change

    Published in Swissreg on 26.01.2022

  6. Jun 9, 2021

    Agent entered

    Representative
    Murgitroyd & Company, 4, Rue du Commerce, 1204 Genève

    Published in Swissreg on 09.06.2021

  7. Mar 17, 2021

    Granted

    Published in Swissreg on 17.03.2021

Parties

Holder

Illumina Cambridge Limited

19 Granta Park Great Abington, Cambridge CB21 6DF, GB

Agent

Murgitroyd & Company

4, Rue du Commerce, 1204 Genève

Inventor

WU, Xiaolin

Nr Saffron Walden, Essex CB10 1XL, GB

LIU, Xiaohai

Nr Saffron Walden, Essex CB10 1XL, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.